102
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Risk Factors for Chronic Obstructive Pulmonary Disease in the Middle-Aged and Elderly Rural Population of Northeast China Using Logistic Regression and Principal Component Analysis

ORCID Icon, , , , ORCID Icon, , ORCID Icon, , , , , , , , , , & ORCID Icon show all
Pages 1717-1726 | Received 29 May 2022, Accepted 06 Sep 2022, Published online: 11 Sep 2022

References

  • GOLD Scientific Committee, Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–1276. doi:10.1164/ajrccm.163.5.2101039.
  • Lareau SC, Fahy B, Meek P, Wang A. Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2019;199(1):P1–P2. doi:10.1164/rccm.1991P1
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
  • Rabe KF, Hurd S, Anzueto A, et al.; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: gOLDexecutive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
  • Murgia N, Gambelunghe A. Occupational COPD-The most under-recognized occupational lung disease? Respirology. 2022;27(6):399–410. doi:10.1111/resp.14272
  • Soriano JB, Kendrick PJ, Paulson KR; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990‐2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-3
  • Burney P, Patel J, Minelli C, et al. Prevalence and population attributable risk for chronic airflow obstruction in a large multinational study. Am J Respir Crit Care Med. 2020;203(11):1353–1365.
  • World Health Statistics. Monitoring health for the SDGs. World Health Organization; 2017. Available from: http://www.who.int/gho/publications/world_health_statistics/2017/en/. Accessed October 6, 2017.
  • IEA. World Energy Outlook 2017. International energy agency publications; 2017.
  • GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi:10.1016/S0140-6736(17)32152-9
  • Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
  • Sainani KL. Logistic regression. PM R. 2014;6(12):1157–1162. doi:10.1016/j.pmrj.2014.10.006
  • Huang T, Li J, Zhang W. Application of principal component analysis and logistic regression model in lupus nephritis patients with clinical hypothyroidism. BMC Med Res Methodol. 2020;20(1):99. doi:10.1186/s12874-020-00989-x
  • Cadima J, Cerdeira JO, Minhoto M. Computational aspects of algorithms for variable selection in the context of principal components. Comput Stat Data Anal. 2004;47(2):225–236. doi:10.1016/j.csda.2003.11.001
  • Ricciardi C, Valente AS, Edmund K, et al. Linear discriminant analysis and principal component analysis to predict coronary artery disease. Health Informatics J. 2020;26(3):2181–2192. doi:10.1177/1460458219899210
  • Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans a Math Phys Eng Sci. 2016;374(2065):20150202. doi:10.1098/rsta.2015.0202
  • Ringner M. What is principal component analysis? Nat Biotechnol. 2008;26(3):303–304. doi:10.1038/nbt0308-303
  • Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.00124605
  • Zhu B, Wang Y, Ming J, et al. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;27(13):1353–1364. doi:10.2147/COPD.S161555
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
  • Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet. 2007;370(9589):741–750. doi:10.1016/S0140-6736(07)61377-4
  • Han R, Zou J, Shen X, et al. [The risk factors of chronic obstructive pulmonary disease in Heilongjiang province]. Zhonghua Jie He He Hu Xi Za Zhi. 2015;38(2):93–98. Chinese.
  • Brandsma C-A, de Vries M, Costa R, et al. Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Eur Respir Rev. 2017;26(146):170073. doi:10.1183/16000617.0073-2017
  • D’Ascanio M, Viccaro F, Calabrò N, et al. Assessing static lung hyperinflation by whole-body plethysmography, helium dilution, and Impulse Oscillometry System (IOS) in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15(15):2583–2589. doi:10.2147/COPD.S264261
  • Meiners S, Eickelberg O, Königshoff M. Hallmarks of the ageing lung. Eur Respir J. 2015;45(3):807–827. doi:10.1183/09031936.00186914
  • Sobrino E, Irazola VE, Gutierrez L, et al. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies. BMC Pulm Med. 2017;17(1):187. doi:10.1186/s12890-017-0537-9
  • He MZ, Zeng X, Zhang K, Kinney PL. Fine particulate matter concentrations in urban Chinese cities, 2005–2016: systematic review. Int J Environ Res Public Health. 2017;14(2):191. doi:10.3390/ijerph14020191
  • Cheng X, Li J, Zhang Z. Analysis of basic data of the study on prevention and treatment of COPD and chronic cor pulmonale. Zhonghua Jie He He Hu Xi Za Zhi. 1998;21:749–752.
  • Xu F, Yin X, Zhang M, Shen H, Lu L, Xu Y. Prevalence of physician-diagnosed COPD and its association with smoking among urban and rural residents in regional mainland China. Chest. 2005;128:2818–2823.
  • Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet. 2011;378(9795):991–996. doi:10.1016/S0140-6736(11)60990-2
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. doi:10.1016/S0140-6736(07)61380-4
  • Liu S, Zhou Y, Wang X, et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax. 2007;62(10):889–897. doi:10.1136/thx.2006.061457
  • Hopkinson NS. COPD, smoking, and social justice. Lancet Respir Med. 2022;10(5):428–430. doi:10.1016/S2213-2600(22)00130-8
  • Pezzuto A, Lionetto L, Ricci A, et al. Inter-individual variation in CYP2A6 activity and chronic obstructive pulmonary disease in smokers: perspectives for an early predictive marker. Biochim Biophys Acta Mol Basis Dis. 2021;1867(1):165990. doi:10.1016/j.bbadis.2020.165990
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD; 2021. Available from http://www.goldcopd.org/. Accessed November 20, 2021.
  • Quint JK, Wedzicha JA. The neutrophil in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2007;119(5):1065–1071. doi:10.1016/j.jaci.2006.12.640
  • Gamble E, Grootendorst DC, Hattotuwa K, et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J. 2007;30(3):467–471. doi:10.1183/09031936.00013006
  • Baraldo S, Turato G, Badin C, et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax. 2004;59(4):308–312. doi:10.1136/thx.2003.012146
  • Tanni SE, Pelegrino NR, Angeleli AY, et al. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J Inflamm. 2010;7(1):29. doi:10.1186/1476-9255-7-29
  • Johannessen A, Omenaas ER, Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005;60(10):842–847. doi:10.1136/thx.2005.043943
  • Dement J, Welch L, Ringen K, et al. A case-control study of airways obstruction among construction workers. Am J Ind Med. 2015;58(10):1083–1097. doi:10.1002/ajim.22495